TITLE:
R&D Landscape for Breast Cancer through Patent Documents
AUTHORS:
Adelaide M. S. Antunes, Iolanda M. Fierro, Rafaela Di Sabato Guerrante, Priscila Rohem dos Santos, Flavia Maria Lins Mendes
KEYWORDS:
Patent; Breast Cancer; Treatment; R&D Trends
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.4 No.7A,
July
23,
2013
ABSTRACT: Cancer is a leading cause of death
worldwide, and is estimated to be the cause of 13.1 million deaths in 2030.
Breast cancer is the second cancer in the global mortality ranking, considering
both sexes. Due to the burden of breast cancer worldwide, this paper aims to
present an overview of the main R&D efforts focusing on breast cancer
treatment. Patents were retrieved from the Derwent Innovations Index?,
which has a specific code for pharmaceuticals related to breast cancer. A total
of 423 patent documents filed in recent years were identified, of which 126 are
exclusively for breast cancer, 169 for breast cancer and other cancers, and 128 are inventions related to the treatment of cancer and other diseases. The patent documents were
classified into two large groups, the first of which had a predominance of
claims for antibodies, proteins and polypeptides for use in medication
production, while the second focuses on gene therapy, nucleotides and RNA. The country with
the majority of priority
patent applications was found to be the United States, followed by China and Japan.